BN Business News
Add your company to Business Communicator →

BUSINESS NEWS

Search Business News

Find articles by title or summary.

7/29/2021

Quarterly Publication of Individuals Who Have Chosen to Expatriate, as Required by Section 6039G of the Health Insurance Portability and Accountability Act (HIPAA) of 1996, as Amended

The Internal Revenue Service (IRS) has published a quarterly list of individuals who have lost U.S. citizenship, as required by the Internal Revenue Code (IRC) section 6039G, in accordance with the Health Insurance Portability and Accountability Act (HIPAA) of 1996, as amended. The list includes the names of individuals who have relinquished their U.S. citizenship, including long-term residents who are treated as having lost citizenship for purposes of this listing.

7/28/2021

FCC Reforms Inmate Calling Services Rules

The Federal Communications Commission (FCC) has revised its rules for inmate calling services, eliminating a separate rate cap for collect calls and lowering interim interstate rate caps for prisons and jails with high populations. The changes aim to simplify billing and reduce costs for consumers.

7/28/2021

USDA Proposes to End Fee-for-Service Certification for Pet Food

The Food Safety and Inspection Service (FSIS) is proposing to end its fee-for-service certification program for pet food, citing outdated regulations and industry confusion, with both USDA and FDA agencies agreeing on the need for simplification of federal jurisdiction over pet food.

7/28/2021

Proposed New Fee Sites at Custer Gallatin National Forest

The Custer Gallatin National Forest will introduce new fees at three campgrounds and two renovated rental cabins, with the aim of aligning the sites with similar amenities and services, and to fund continued operation and capital improvements. The fees are based on the level of services provided and will be used to maintain and upgrade the facilities.

7/28/2021

US Withdraws Environmental Assessment for Avian Influenza Control Plan

The US Department of Agriculture's Animal and Plant Health Inspection Service is withdrawing its environmental assessment and finding of no significant impact for a national approach to controlling highly pathogenic avian influenza outbreaks in commercial poultry operations, pending further evaluation.

7/28/2021

FDA Clears Fluorouracil Topical Solution for Sale

The US Food and Drug Administration (FDA) has ruled that Fluorouracil topical solution, 5 percent, was not withdrawn from sale due to safety or effectiveness concerns. This decision means the FDA will not initiate withdrawal procedures for the abbreviated new drug application (ANDA) related to this product, and will continue to approve new ANDAs as long as they meet regulatory requirements.

7/28/2021

FDA Announces Generic Drug User Fee Rates for Fiscal Year 2022

The US Food and Drug Administration (FDA) has published the fiscal year 2022 rates for fees associated with the review of generic drug applications, as mandated by the Generic Drug User Fee Amendments of 2017 (GDUFA II). These fees support the FDA's efforts to ensure the safety and efficacy of generic medications.

7/28/2021

FDA Issues Final Debarment Order Against Justin Ash for 5 Years

The FDA is issuing a 5-year final debarment order against Justin Ash for his conviction of conspiracy to commit offenses against the US, related to the importation of a controlled substance. Mr. Ash failed to respond to a proposed debarment notice, waiving his right to a hearing.

7/28/2021

FDA Issues Final Debarment Order Against Jacobo Geissler for 5 Years

The FDA has issued a 5-year final debarment order against Jacobo Geissler, prohibiting him from importing food articles into the US due to a felony conviction related to food importation. Geissler failed to respond to the proposed debarment notice within the required timeframe, waiving his right to a hearing.

7/28/2021

FDA Clears CECLOR CD Tablets for Certain Indications, Suspends Approval for Secondary Bacterial Infections of Acute Bronchitis

The FDA has determined that CECLOR CD tablets, 375mg and 500mg, were not withdrawn from sale due to safety or effectiveness concerns, except for the indication of secondary bacterial infections of acute bronchitis, which was also withdrawn for the same reasons. This decision allows the FDA to continue approving abbreviated new drug applications for these products, but suspends approval for those that include SBIAB as an indication.

7/28/2021

FDA Announces Fiscal Year 2022 Outsourcing Facility Fee Rates

The Food and Drug Administration (FDA) has set the fiscal year 2022 rates for establishment and reinspection fees for outsourcing facilities that manufacture human drugs, effective October 1, 2021, and will remain in effect through September 30, 2022.